CRYSFORMA, a unit from the Institute of Chemical Research of Catalonia (ICIQ) managed by Dr. Jordi Cerón, provides complete scientific support to the pharmaceutical and fine chemistry industry in the field of pharmaceutical solid state development. CRYSFORMA is currently applying its expertise to use the ALBA synchrotron facilities in its projects in the area of polymorphism.
ALBA Synchrotron achieves with this agreement with Henkel one of his main targets: collaboration with industry based on research and development at the highest scientific and technological level. Henkel is the first company signing a R&D collaboration agreement with ALBA regarding industrial applications of synchrotron techniques. With this agreement Henkel reinforces its already proved capacity on R&D and decides to support the ALBA Synchrotron capacities.
